StockNews.com began coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note published on Wednesday morning. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
NASDAQ:CALA opened at $0.01 on Wednesday. Calithera Biosciences has a 12-month low of $0.00 and a 12-month high of $0.12. The business has a 50 day simple moving average of $0.01 and a 200 day simple moving average of $0.02.
About Calithera Biosciences
See Also
- Five stocks we like better than Calithera Biosciences
- 10 Best Airline Stocks to Buy
- Texas Roadhouse Stock Steering for New Highs This Year
- How Investors Can Find the Best Cheap Dividend Stocks
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What Investors Need to Know About Upcoming IPOs
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.